All Posts By

Ben Kemp

BIVDA Webinar: What could quantum sensing mean for the future of IVDs? Membership NewsMembership News Archive

BIVDA Webinar: What could quantum sensing mean for the future of IVDs?

BIVDA members are invited to join experts from the Q-BIOMED hub for an interactive session on Tuesday 16th June at 1pm - 2pm on how quantum sensing technologies could reshape the way disease is detected, measured, and understood across clinical pathways. This webinar will unpack the science behind these emerging approaches in an accessible way, asking questions such as: how…
Ben Kemp
April 27, 2026
NIHR launches global programme to tackle antimicrobial resistance (AMR) HighlightsHighlights Archive

NIHR launches global programme to tackle antimicrobial resistance (AMR)

The National Institute for Health and Care Research (NIHR) has announced a new global health funding opportunity to combat AMR. The initiative, funded by the Department of Health and Social Care (DHSC), will allow researchers to apply for between £500,000 and £5 million to transform their promising research into solutions which can be embedded into daily clinical practice. The programme…
Ben Kemp
April 24, 2026
BIVDA welcomes new members: Molbio Diagnostics, OPD (Oxford Product Design) and Imprinted Diagnostics Membership NewsMembership News Archive

BIVDA welcomes new members: Molbio Diagnostics, OPD (Oxford Product Design) and Imprinted Diagnostics

This week, we are pleased to welcome three new members to our community: Molbio Diagnostics, OPD (Oxford Product Design) and Imprinted Diagnostics. Imprinted Diagnostics have created a portable blood test for high sensitivity troponin I for use in a pre-hospital environment, with a mission to deliver fast, accurate diagnosis anywhere; saving lives and closing the healthcare gap in underserved regions.…
Ben Kemp
April 24, 2026
NHS Supply Chain Market Engagement Notice: In-Vitro Diagnostics, Point of Care Testing & Pathology Services Membership NewsMembership News ArchiveProcurement Working PartyProcurement Working Party Archive

NHS Supply Chain Market Engagement Notice: In-Vitro Diagnostics, Point of Care Testing & Pathology Services

NHS Supply Chain intends to launch a National Framework Agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products & Related Pathology Services, this will include: - Pathology Managed Services - Reagent Rental Agreements - Pathology Maintenance Services - Pathology Software - Pathology Outsourced Services (Referral Testing Services) - Core Laboratory Equipment, Instruments & Consumables, to cover…
Ben Kemp
April 15, 2026
Register – OLS & DBT UK-India Free Trade Agreement: Life Sciences Roundtable Membership NewsMembership News Archive

Register – OLS & DBT UK-India Free Trade Agreement: Life Sciences Roundtable

BIVDA members are invited to participate in a focused roundtable exploring the UK–India Free Trade Agreement and the emerging opportunities for Life Sciences businesses across pharmaceuticals, medical technology, and healthcare. The event is being run by the Office for Life Sciences (OLS) and the Department of Business and Trade (DBT) and is being hosted in the BIVDA office. This session…
Ben Kemp
April 15, 2026
BIVDA Glue Up user guide for members Membership NewsMembership News Archive

BIVDA Glue Up user guide for members

To assist members with navigating our new membership platform, Glue Up, we have produced a helpful user guide for members. This should help members to make the most of Glue Up – from getting involved in events to ensuring you receive all of the comms you need. Sections covered are: My Glue Up homepage, Member Directory, Events, Membership, Subscriptions and…
Ben Kemp
April 15, 2026
2 weeks to go to until BIVDA’s Spring Sustainability Seminar Membership NewsMembership News Archive

2 weeks to go to until BIVDA’s Spring Sustainability Seminar

There are only 2 weeks to go until BIVDA's Spring Sustainability Seminar. The seminar takes place on Tuesday 28th April 2026 at 10am - 4pm and provides BIVDA members with the opportunity to hear the latest information on social value, NHS sustainability goals, and Net Zero affecting IVDs with key stakeholders, including: Heidi Barnard, Head of Sustainability, NHS Supply Chain…
Ben Kemp
April 13, 2026
Media Monitoring: 2nd – 15th April HighlightsHighlights Archive

Media Monitoring: 2nd – 15th April

Genetic cause identified for 1 in 4 MND patients in largest ever rare variant analysis Project MinE, an international consortium co-founded by researchers at King’s College London, has identified new genetic variants that play a role in the development of motor neuron disease (MND). These findings mean that a genetic component is identifiable for 1 in 4 people with MND,…
Ben Kemp
April 13, 2026
Chinese manufacturer seeking distribution partnership with UK companies Membership NewsMembership News Archive

Chinese manufacturer seeking distribution partnership with UK companies

Following on from BIVDA's role in the government's IVD mission to China, we have been contacted by a Chinese manufacturer, Shanghai GeneoDx Biotech, who are seeking a distribution partner in the UK for their products, including TP3, monkeypox assays, POC products and tumour methylation instruments. They are also looking to partner with UK IVD companies with mature products and early…
Ben Kemp
April 10, 2026
NHS Trust pioneers painless new blood test to help those with phobias and learning disabilities HighlightsHighlights Archive

NHS Trust pioneers painless new blood test to help those with phobias and learning disabilities

Patients with learning disabilities and needle phobia are benefiting from a painless new form of blood sampling pioneered by University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT). The initiative utilises a small, touch-activated ‘TAP’ device applied to the upper arm to collect blood painlessly. Since April 2025, UHMBT has successfully supported nearly 50 patients who previously could not provide blood…
Ben Kemp
April 10, 2026